-+ 0.00%
-+ 0.00%
-+ 0.00%

DuPont (DD) Stock May Trade At A Discount Despite Lithium Extraction Launch

Simply Wall St·07/24/2026 16:38:12
Listen to the news

DuPont de Nemours has delivered a 59.9% return over the past five years, yet its valuation checks are split, with the Discounted Cash Flow (DCF) intrinsic value pointing to meaningful upside while traditional market multiples suggest the stock screens as expensive.

  • Over five years, DuPont de Nemours has returned 59.9%. This puts current investors squarely in the camp of asking how much of the story is already reflected in the price.
  • Growth expectations around DuPont de Nemours' roles in personal protective equipment and direct lithium extraction can support optimism on future cash flows. At the same time, ongoing legal challenges linked to PFAS lawsuits may weigh on how much of that potential investors are willing to price in today.
  • The company scores 3 out of 6 on our valuation checks, which points to a mixed picture rather than a clear bargain or clear overvaluation.

The issue now is whether DuPont de Nemours' share price at US$137.40 offers enough margin of safety when the DCF suggests it is undervalued by 36.3% but earnings based multiples lean rich.

Find out why DuPont de Nemours' 49.1% return over the last year is lagging behind its peers.

Is DuPont de Nemours a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) approach estimates what DuPont de Nemours is worth based on the cash it can generate for shareholders over time. For DuPont de Nemours, the model starts from latest twelve month free cash flow of about $892.3 million and assumes that cash flows grow rather than shrink, but at relatively moderate rates instead of aggressive step changes.

On these assumptions, the DCF points to an intrinsic value of about $215.79 per share, compared with the current share price of $137.40, implying the stock screens as 36.3% undervalued. Recent headlines around DuPont launching an end to end direct lithium extraction portfolio help explain why some investors may see room for those cash flows to hold up, even as ongoing PFAS legal issues remain in focus.

On the DCF numbers alone, DuPont de Nemours looks undervalued relative to the cash flows analysts expect it to produce.

Our Discounted Cash Flow (DCF) analysis suggests DuPont de Nemours is undervalued by 36.3%. Track this in your watchlist or portfolio, or discover 38 more high quality undervalued stocks.

DD Discounted Cash Flow as at Jul 2026
DD Discounted Cash Flow as at Jul 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for DuPont de Nemours.

Does DuPont de Nemours Look Pricey on Earnings?

The P/E ratio is a useful way to think about what you are paying today for each dollar of DuPont de Nemours' earnings. On this measure, DuPont de Nemours trades on about 140.5x earnings, far above both the Chemicals industry average of 25.2x and a peer group average of 20.8x.

A more tailored fair P/E multiple for DuPont de Nemours, based on factors such as its growth profile, margins, size and risk, is around 29.2x. The fact that the current P/E is several times higher than this suggests the market is pricing in a lot of optimism and is heavily discounting risks like the ongoing PFAS legal issues. The model is effectively signalling that, on earnings, the stock screens as very expensive rather than pointing to a precise fair value target.

On the P/E multiple, DuPont de Nemours currently looks overvalued compared with both its sector and what the tailored model suggests would be a more grounded earnings multiple.

NYSE:DD P/E Ratio as at Jul 2026
NYSE:DD P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The DuPont de Nemours Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where this DuPont de Nemours valuation puzzle leaves off. They spell out the specific growth, margin and earnings paths that would need to play out for the stock to be worth materially more or less than its current price on the market. Each one links its number to a clear view on how growth, profitability and risks could evolve so you can revisit those assumptions on the Community page as fresh information comes through.

The DuPont de Nemours community is split, with one camp seeing significant upside potential and the other focused on long running structural risks.

Bull case: 28% undervalued

"DuPont's leadership in advanced materials for EVs, lightweighting, and electrification, combined with a sharpened R&D focus post-spin, positions the company to capture disproportionate share of the rapid global shift toward electric transportation..."

Read the full Bull Case to see why DuPont de Nemours could be undervalued

Bear case: 175% overvalued

"Intensifying global ESG and environmental regulations are poised to increase DuPont's long-term compliance and remediation costs, especially as ongoing PFAS and other environmental liabilities continue to create significant legal and cash flow burdens over the next decades, which will erode net margins and suppress future earnings growth..."

Read the full Bear Case to see why DuPont de Nemours could be overvalued

Do you think there's more to the story for DuPont de Nemours? Head over to our Community to see what others are saying!

The Bottom Line

For DuPont de Nemours, the Discounted Cash Flow (DCF) intrinsic value points to meaningful upside, while the earnings based view flags the stock as overvalued on a very stretched P/E multiple. That split reflects a market willing to pay a high price for earnings today, and a cash flow model that assumes DuPont can support those cash flows over time. With broader valuation checks sitting in the middle, the key question is whether future cash flows materialise despite PFAS related legal risks, or whether the current earnings multiple already reflects more optimism than the business and its liabilities can sustain.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.